Remove Company Remove Ethics Remove Pharmaceuticals Remove Price
article thumbnail

Ethics Is Serious Business

Great Leadership By Dan

The field that provides this kind of know-how is called ethics. This means that ethics is serious business. Ethical dilemmas are at least as hard to resolve as engineering problems, and at least as urgent, particularly in our complex and fast-moving world. When does pharmaceutical pricing become price gouging?

Ethics 197
article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. At Harvard's Edmond J.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Introducing 100 Coaches: Pay It Forward Champions

Marshall Goldsmith

US News and World Report #1 Best Hospital in the United States – Fortune ‘100 Best Companies to Work For,’ 14 consecutive years. Liz Smith – Chairman and CEO, Bloomin’ Brands (Outback, Flemings, Carrabba’s, Bonefish Grill) – one of the world’s largest casual dining companies. Garry Ridge – CEO, WD-40 Company.

article thumbnail

Solving the $100,000 Cancer Drug Problem

Harvard Business Review

Last week over 100 leading cancer specialists signed their names to an op-ed in Blood , the journal of the American Society of Hematology, which lambasted the prices of cancer drugs that often exceed $100,000 annually. While pharma companies spend billions on research, the actual cost of manufacturing a treatment (such as a pill) is minimal.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Merck and Co. Integration is key.

article thumbnail

7 Tricky Work Situations, and How to Respond to Them

Harvard Business Review

Katie is the COO of a hospitality company. She dreads saying that she has to leave to relieve the nanny because she knows that her colleagues may judge her as having a poor work ethic. Saturday night, with an idea that could give the company an edge in customer service call hold times. She has a keen strategic mind.

EVA 8
article thumbnail

The Tempting of Rajat Gupta

Harvard Business Review

Competitors whispered that Gupta was committing the most un-McKinsey-like of sins: cutting price to get into new markets. Among McKinsey's biggest clients in the 1990s were pharmaceuticals and financial-services companies. pharma companies equaled the total for the other 490 in the Fortune 500?